Marc Lippman

Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.

Founded in 1995, Perseus LLC(Perseus) is a merchant banking and private equity fund management firm located in Bethesda, Maryland.

Alpha Omega Alpha Honor Medical Society is a national medical honor society founded in 1902. The non-profit company is based in Menlo Park, CA. The society's mission is to foster the development of the next generation of medical researchers by recognizing high educational achievement, honoring gifted teaching, encouraging the development of leaders in academia and the community, and supporting the improvement of care for all.

National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.

Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA.

Aurora Biopharma, Inc. develops Chimeric Antigen Receptor (CAR) T therapy, cancer vaccines, and combinations with checkpoint Inhibitors services. It develops Aurora’s “Bionic” T Cells : CAR T-Cells engineered to kill cancer and Aurora’s Revolutionary CAR T cell Clinical Cancer Trials. The company was founded by Robert Brooks and Marc Lippman and is headquartered in Cambridge, MA.

Georgetown Lombardi Comprehensive Cancer Center is a comprehensive cancer center designated by the National Cancer Institute (NCI) and is a part of Georgetown University Medical Center. It is located in Washington, D.C. and is supported in part by a National Cancer Institute Cancer Center Support Grant. It is the only comprehensive cancer center in the area and serves as the research engine for MedStar Health, Georgetown University’s clinical partner. Georgetown Lombardi seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic, translational, and clinical research, patient care, and community education and outreach. Georgetown Lombardi also offers a master’s degree program in cancer biology, prevention, and control in partnership with the University of the District of Columbia (UDC).